VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 36 filers reported holding VINCERX PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,703,413 | $1,720,447 | 0.48% |
| Tejara Capital Ltd | 233,348 | $235,681 | 0.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $388,850 | 0.04% |
| SABBY MANAGEMENT, LLC | 57,353 | $57,927 | 0.04% |
| Long Focus Capital Management, LLC | 1,098,753 | $1,109,741 | 0.04% |
| Sio Capital Management, LLC | 102,049 | $103,069 | 0.03% |
| Rock Springs Capital Management LP | 891,719 | $900,636 | 0.02% |
| Rubric Capital Management LP | 354,377 | $357,921 | 0.01% |
| Clearline Capital LP | 98,916 | $99,905 | 0.01% |
| ExodusPoint Capital Management, LP | 389,512 | $393 | 0.00% |
| XTX Topco Ltd | 16,845 | $17,350 | 0.00% |
| Schonfeld Strategic Advisors LLC | 114,000 | $115,140 | 0.00% |
| Point72 Asset Management, L.P. | 344,827 | $348,275 | 0.00% |
| GOLDMAN SACHS GROUP INC | 2,062,926 | $2,083,555 | 0.00% |
| MORGAN STANLEY | 24,822 | $25,071 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 41,830 | $42 | 0.00% |
| BlackRock Inc. | 64,259 | $64,902 | 0.00% |
| Citadel Advisors | 168,829 | $173,893 | 0.00% |
| BARCLAYS PLC | 2,556 | $3 | 0.00% |
| Renaissance Technologies | 132,900 | $134 | 0.00% |
External links
This page lists VINCERX PHARMA INC's shareholders in Q3 2023. To view VINCERX PHARMA INC's shareholder history, click here.